REAL-WORLD EFFECTIVENESS OF BRENTUXIMAB VEDOTIN VS OTHER TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA POST AUTOLOGOUS STEM-CELL TRANSPLANTATION

被引：0
作者：
Zagadailov, E. A. [1 ]
Corman, S. [2 ]
Hagan, M. [3 ]
Chirikov, V. [2 ]
Johnson, C. [2 ]
Macahilig, C. [3 ]
Sea, B. [1 ]
Dalal, M. R. [1 ]
Broeckelmann, P. J. [4 ,5 ]
Illidge, T. [6 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Pharmerit Int, Bethesda, MD USA
[3] Med Data Analyt, Parsippany, NJ USA
[4] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[5] Univ Hosp Cologne, GHSG, Cologne, Germany
[6] Univ Manchester, Inst Canc Sci, Christie Hosp, Manchester, Lancs, England
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P094
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] Brentuximab Vedotin Plus Chemotherapy As Pre-Autologous Stem Cell Transplantation Salvage Treatment in Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from Peru
    Quintana, Shirley
    Vasquez, Jule F.
    Lopez, Lourdes
    Alcarraz, Cindy
    Flores, Claudio
    Samanez-Figari, Cesar
    BLOOD, 2020, 136
  • [22] Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
    Marouf, Amira
    Cottereau, Anne Segolene
    Kanoun, Salim
    Deschamps, Paul
    Meignan, Michel
    Franchi, Patricia
    Sibon, David
    Antoine, Clara
    Gastinne, Thomas
    Borel, Cecile
    Hammoud, Mohammad
    Sicard, Guillaume
    Gille, Romane
    Cavalieri, Doriane
    Stamatoullas, Aspasia
    Filliatre-Clement, Lauriane
    Lazarovici, Julien
    Chauchet, Adrien
    Fornecker, Luc-Matthieu
    Amorin, Sandy
    Rocquet, Mathieu
    Raus, Nicole
    Burroni, Barbara
    Rubio, Marie Therese
    Bouscary, Didier
    Quittet, Philippe
    Casasnovas, Rene Olivier
    Brice, Pauline
    Ghesquieres, Herve
    Tamburini, Jerome
    Deau, Benedicte
    HAEMATOLOGICA, 2022, 107 (07) : 1681 - 1686
  • [23] COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT IN TAIWAN
    Zou, D.
    Kendall, R.
    Lin, Q.
    Huang, Y.
    Tieng, J.
    Tseng, J.
    Sajosi, P.
    VALUE IN HEALTH, 2016, 19 (07) : A888 - A888
  • [24] Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma
    Kenichi Ishizawa
    Tomoko Yanai
    Advances in Therapy, 2019, 36 : 2679 - 2696
  • [25] Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma
    Damlaj, Moussab
    Abuelgasim, Khadega A.
    Alhejazi, Ayman
    Alahmari, Bader
    Alaskar, Ahmed
    Alzahrani, Mohsen
    BONE MARROW TRANSPLANTATION, 2020, 55 (12) : 2322 - 2325
  • [26] Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma
    Ishizawa, Kenichi
    Yanai, Tomoko
    ADVANCES IN THERAPY, 2019, 36 (10) : 2679 - 2696
  • [27] Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma
    Moussab Damlaj
    Khadega A. Abuelgasim
    Ayman Alhejazi
    Bader Alahmari
    Ahmed Alaskar
    Mohsen Alzahrani
    Bone Marrow Transplantation, 2020, 55 : 2322 - 2325
  • [28] THE COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HODGKIN LYMPHOMA AND INCREASED RISK OF RELAPSE
    Ringkvist, J.
    Engstrom, A.
    VALUE IN HEALTH, 2017, 20 (09) : A437 - A437
  • [29] Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study
    Iannitto, Emilio
    Romano, Alessandra
    Scalzulli, Potito Rosario
    Bonanno, Vincenza
    Scalone, Renato
    Chiarenza, Annalisa
    Pirosa, Maria Cristina
    Caruso, Anastasia Laura
    Minoia, Carla
    Mantuano, Saverio
    De Santis, Gaetano
    Salerno, Marilena
    Crescimanno, Alessandra
    Porretto, Ferdinando
    Li Gioi, Felicina
    Ricciuti, Giuseppina
    Greco, Antonino
    Pavone, Enzo
    Guarini, Attilio
    Tarantini, Giuseppe
    Mannina, Donato
    Consoli, Ugo
    Cascavilla, Nicola
    Di Raimondo, Francesco
    Musso, Maurizio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (06) : 581 - 587
  • [30] Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma
    Kort, Jeries
    Chidiac, Amanda
    El Sayed, Rola
    Massoud, Radwan
    Nehme, Rita
    Bazarbachi, Ali
    El-Cheikh, Jean
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1732 - 1735
12345